Literature DB >> 17608833

Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation.

A Massaguer1, S Ramírez, J A Carrión, P González, J M Sánchez-Tapias, X Forns.   

Abstract

In patients with hepatitis C virus (HCV)-related cirrhosis, infection recurrence is universal after liver transplantation (LT). The relevance of host and virus-related factors on the outcome of hepatitis C recurrence is poorly understood. This study analyzed the relationship between the genetic evolution of the Non-Structural (NS)3 protease and NS5B polymerase regions of HCV and the severity of hepatitis C recurrence. Thirty-three patients were classified as having mild (n = 16) or severe recurrence (n = 17), according to the degree of fibrosis in liver biopsies obtained 1 year after transplantation. Viral load and consensus sequences of the NS3 and NS5B domains were determined in a pre-LT and in four post-LT sequential serum samples. At week 12 after LT, viremia was significantly higher in patients with severe recurrence. NS3 and NS5b regions evolved independently after LT. The genetic evolution of NS3 domain was not related to the severity of the recurrence. However, the diversification in the NS5B region later than 12 weeks after LT was greater in patients with mild than in those with severe recurrence, suggesting a stronger immune pressure in the first group. These observations highlight the complex interplay between viral evolution and clinical outcomes in the LT setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608833     DOI: 10.1111/j.1600-6143.2007.01894.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

1.  Unexpected maintenance of hepatitis C viral diversity following liver transplantation.

Authors:  Rebecca R Gray; Samantha L Strickland; Nazle M Veras; Maureen M Goodenow; Oliver G Pybus; Stanley M Lemon; Michael W Fried; David R Nelson; Marco Salemi
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  HCV in liver transplantation.

Authors:  Giacomo Germani; Emmanuel Tsochatzis; Vasilios Papastergiou; Andrew K Burroughs
Journal:  Semin Immunopathol       Date:  2012-07-25       Impact factor: 9.623

3.  Antiviral treatment for hepatitis C virus infection after liver transplantation.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  Hepat Res Treat       Date:  2010-11-01

4.  Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients.

Authors:  Meritxell Llorens-Revull; Josep Gregori; Cristina Dopazo; Francisco Rodriguez-Frías; Damir Garcia-Cehic; Maria Eugenia Soria; Qian Chen; Ariadna Rando; Celia Perales; Juan Ignacio Esteban; Josep Quer; Itxarone Bilbao
Journal:  Genes (Basel)       Date:  2021-10-28       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.